Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Atherosclerosis Plus|February 27, 2026
LDL-C lowering in patients treated with bempedoic acid in a real-world cohortJames Nelson, LeAnne Bloedon, Dave Lewandowski, et al.
Journal of Clinical Lipidology|December 14, 2025
Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trialVenu Menon, LeAnne Bloedon, Na Li, et al.
Cardiology and Therapy|July 14, 2024
Prevalence of Tendon Rupture and Tendinopathies Among Patients with Atherosclerotic Cardiovascular Disease Derived From United States Administrative Claims DataKristin K Gillard, LeAnne Bloedon, John C Grady-Benson, et al.
Journal of the American Heart Association|February 8, 2025
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset AnalysisHarold E Bays, LeAnne Bloedon, Danielle Brennan, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 20, 2025
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes TrialStephen J Nicholls, Kausik K Ray, A Michael Lincoff, et al.
JAMA Cardiology|January 17, 2024
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical TrialStephen J Nicholls, Adam J Nelson, A Michael Lincoff, et al.
European Journal of Preventive Cardiology|February 16, 2026
Effect of bempedoic acid on cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver diseaseVivian D de Jong, Steven E Nissen, William J Sasiela, et al.
Journal of Clinical Lipidology|February 12, 2025
Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trialUlrich Laufs, A Michael Lincoff, Stephen J Nicholls, et al.
Clinical Cardiology|July 30, 2024
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes TrialAbhayjit Singh, Luke J Laffin, Ashish Sarraju, et al.
Journal of the American Heart Association|June 23, 2026
Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic AcidG B John Mancini, A Michael Lincoff, Anne C Goldberg, et al.
Pageof 2